(2E)-3-[4-(benzyloxy)phenyl]-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 2g

6-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one, 97.0%, 5g

5-Sulfosalicylic Acid Dihydrate [for Biochemical Research]>98.0%(HPLC)(T)25g

2-Thiopheneethylamine, 98.0%, 10g

Methyl (S)-2-(4-(4-chlorophenyl)-2-(hydroxymethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate, 98%, 50mg

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 2000 ml, 29/32, 19/26, 1 unidad

1-(3-Bromo-5-iodophenyl)ethan-1-one, 98%, 250mg

2-Bromo-3-thiophenecarboxylic acid, 95.0%, 5g

4-Chloro-2-fluoro-1-(trifluoromethyl)benzene, 95.0%, 5g

2-(4-isopropylpiperazine-1-carbonyl)benzoic acid, 95.0%, 500mg

3,4-dimethyl-4'-(1,3-dioxolan-2-yl)benzophenone, 97.0%, 1g

4-(4-(Benzyloxy)benzyl)piperidine hydrochloride, 97%, 5g

8-Hydroxyquinoline-5-sulfonic acid hydrate, 95.0%, 5g